Drug Shortage Report for BROMAZEPAM-3 - TAB 3MG

Last updated on 2018-09-07 History
Report ID 58785
Drug Identification Number 02220520
Brand name BROMAZEPAM-3 - TAB 3MG
Common or Proper name BROMAZEPAM
Company Name PRO DOC LIMITEE
Market Status CANCELLED POST MARKET
Active Ingredient(s) BROMAZEPAM
Strength(s) 3MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 500
ATC code N05BA
ATC description ANXIOLYTICS
Reason for shortage Demand increase for the drug.
Anticipated start date 2018-09-06
Actual start date
Estimated end date 2018-09-06
Actual end date 2018-09-06
Shortage status Resolved
Updated date 2018-09-07
Company comments
Health Canada comments
Contact Address 2925 BOULEVARD INDUSTRIEL
LAVAL, QUEBEC
CANADA H7L 3W9
Company contact information 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2018-09-07 English Compare
v10 2018-09-06 French Compare
v9 2018-09-06 English Compare
v8 2018-09-04 French Compare
v7 2018-09-04 English Compare
v6 2018-09-04 French Compare
v5 2018-09-04 English Compare
v4 2018-08-29 French Compare
v3 2018-08-29 English Compare
v2 2018-08-22 French Compare
v1 2018-08-22 English Compare